This bill reauthorizes federal programs focused on preventing and responding to tick-borne diseases through 2026-2030, extending existing efforts beyond their previous expiration. It updates the National Strategy for Vector-Borne Diseases to emphasize identifying, reporting, preventing, and responding to these illnesses. The bill modifies two sections of the Public Health Service Act to continue funding for health departments working on vector-borne disease control. It directly affects public health programs and state/local health departments managing tick-borne disease prevention and response.
The AADAPT Act reauthorizes and expands Project ECHO grants to improve Alzheimer’s and dementia care through technology-enabled training. It specifically funds grants for healthcare providers in rural, frontier, or medically underserved areas to enhance early diagnosis, quality care, and provider retention for dementia patients. The bill authorizes $1 million annually (2027-2032) for these dementia-focused training programs, requiring funds to supplement - not replace - existing resources. This directly supports primary care providers licensed to serve underserved communities, using collaborative online learning to address care gaps.
This bill reauthorizes the National Earthquake Hazards Reduction Program through fiscal year 2030, providing $83.4 million annually with $30 million each year dedicated to completing the Advanced National Seismic System. It expands the program to include Tribal governments, updates standards to cover building design, evaluation, and post-earthquake recovery (such as minimizing downtime for critical infrastructure), and requires better coordination between federal agencies like the USGS, Federal Communications Commission, and FEMA for earthquake early warnings. The bill mandates that early warning alerts be broadcast in the predominant languages of affected regions and includes new provisions for tsunami response coordination and data sharing.
HR 2821, the FDA Modernization Act 3.0, requires the FDA to update regulatory language within one year of enactment. It directs the agency to replace all references to "animal tests" with "nonclinical tests" in 22 specific sections of the Code of Federal Regulations related to drug development and approval processes. The bill also adds a definition for "nonclinical test" into relevant FDA regulations to align with prior legislative changes. This update applies directly to pharmaceutical manufacturers and FDA reviewers who follow these regulatory guidelines during drug development. The changes aim to modernize terminology without altering current testing requirements.
HR 183, the Law Enforcement Officer Recreation Pass Act, creates a free, lifetime National Parks and Federal Recreational Lands Pass for qualifying law enforcement officers. It directly affects federal, state, local, and tribal officers authorized to prevent, detect, or investigate criminal law violations or supervise offenders. The bill amends existing law to require the Secretary to provide this pass without charge, making it available for the passholder's lifetime. This is a concrete policy change expanding access to federal recreation areas for eligible officers, with no cost to them. The bill does not cover firefighters or other public safety personnel.
This resolution supports designating July 20, 2026, as "National Moon Landing Day" to honor the historic Apollo 11 mission and the ongoing Artemis program. The bill encourages Americans to celebrate the achievements of NASA astronauts, engineers, and scientists while honoring those who lost their lives during space exploration efforts. It also aims to inspire young people to pursue careers in STEM fields and promote public awareness of the economic and scientific benefits of human spaceflight.
The Judicial Integrity Act amends federal law to clarify how financial conflicts of interest apply to judges and Supreme Court justices. It requires that any financial interests held by these officials be evaluated against a new regulatory exemption process managed by the Judicial Conference. Under this bill, a financial interest can only be considered too small to matter if the Judicial Conference issues a public rule explicitly exempting it after a notice and comment period. This change ensures that exemptions are formalized through official regulations rather than being assumed without review.
The Judicial FOIA Expansion Act requires federal courts to release specific records to the public under the Freedom of Information Act. This law mandates the disclosure of attorney disciplinary actions, complaints against judges, meeting minutes, jury selection forms, and performance reports, while explicitly excluding information about ongoing cases. The bill also directs courts to provide this data in machine-readable formats and authorizes $10 million in funding to establish an office within the Administrative Office of the United States Courts to manage these requirements.
The Justice is BLIND Act of 2026 requires federal judges, including justices, magistrate judges, and bankruptcy judges, along with their spouses and dependent children, to place specific financial investments into blind trusts within 90 days of assuming office. This rule applies to covered financial interests such as stocks, commodities, and derivatives, while explicitly excluding widely held mutual funds, U.S. Treasury securities, and compensation earned by spouses or children from their own employers. Once established, these trusts must remain intact for at least 180 days after the judge leaves office, and the judges must publicly attest to the trust's creation or confirm they hold no such interests on a searchable government database.
The FORMULA Act of 2026 requires the U.S. Food and Drug Administration to set strict limits on contaminants in infant formula, including heavy metals, microplastics, and synthetic pesticides. Manufacturers must test their products to meet these new standards and keep records of their testing for at least two years after the formula's shelf life expires. The law also mandates that the FDA report annually to Congress on any violations and the progress made in reducing contaminant levels in the domestic supply chain. These regulations will take effect 180 days after the bill is signed into law.
The Judicial Integrity Act amends federal law to clarify which judges and Supreme Court justices must recuse themselves from cases involving personal financial interests. It requires that any exemptions from these conflict-of-interest rules be established through a formal regulation issued by the Judicial Conference of the United States, which must include public notice and a comment period. This change ensures that decisions about whether a financial interest is too small to matter are made transparently rather than through individual waivers. The bill directly affects all federal judges and Supreme Court justices by tightening the standards for when they can participate in cases where they have a financial stake.
The Justice is BLIND Act of 2026 requires federal judges, including justices, magistrate judges, and bankruptcy judges, along with their spouses and dependent children, to place specific financial investments into qualified blind trusts within 90 days of taking office or enactment. This rule applies to securities, commodities, and derivatives but excludes widely held mutual funds, U.S. Treasury bonds, and income earned by spouses or children from their own jobs. The bill also mandates that these judges publicly attest to the establishment of the trust or confirm they hold no covered financial interests, with these reports made available online. Additionally, the law prohibits judges from dissolving or controlling these trusts for 180 days after they leave their judicial positions to prevent immediate conflicts of interest.
